glp 1 gip triple agonist Effects, working principles and target tissues of dual agonists Dual and Triple Gut Peptide
Description
Weight regain after discontinuing GLP-1 medications is a documented concern for both drugs
Purchasing supplements from reputable sources and looking for third-party testing certifications can help mitigate these risks, though it does not eliminate them entirely
2024;47(Suppl 1):S15878
65 Exendin-4, a GLP-1 analog, showed cardioprotective properties in a diabetic animal model by preventing heart remodeling and diastolic dysfunction
Starting with lower doses and gradually increasing helps minimize these effects
10.1038/nrendo.2017.173 11
